There are 3 papers on GRNMUTATION in aging research: 3 observational studies in people.
3 papers study it4 findings
“DBScapillary progranulin levels in GRN mutation carriers (mean [SD] age, 55 [13] years; n = 16) were reduced compared to non-mutation carriers”
None of its findings points the other way.
- 3 independent labs in 5 countries
- Funders: Japan Society for the Promotion of Science and others
- 1 of 4 findings with company ties
- Humans3
Effects
3Dried blood spot progranulin levels
downin humans1
1 study
Dried blood spot progranulin levels
downin humans1
GRNMUTATION is linked with lower dried blood spot progranulin levels in humans (heterozygous pathogenic mutation carriers versus non-mutation carriers) (2.38 ng/mL (SD 1.0) vs 4.37 ng/mL (SD 0.68); U = 42; p < 0.0001).
“DBScapillary progranulin levels in GRN mutation carriers (mean [SD] age, 55 [13] years; n = 16) were reduced compared to non-mutation carriers”
Humansheterozygous pathogenic mutation carriers versus non-mutation carriersdried blood spots from capillary finger-stick collectionn = 44
Alzheimer's & dementia : the journal of the Alzheimer's Association
Prosaposin
no changein humans1
1 study
Prosaposin
no changein humans1
GRNMUTATION was not clearly linked with prosaposin in humans (frontotemporal dementia with GRN mutations).
“while PSAP signal was preserved”
Humansfrontotemporal dementia with GRN mutationsbrain
Journal of neuropathology and experimental neurology
Progranulin
downin humans1
1 study
Progranulin
downin humans1
GRNMUTATION is linked with lower progranulin in humans (frontotemporal dementia with GRN mutations) (almost complete absence of PGRN in most neurons).
“The GRN mutation cases exhibited almost complete absence of PGRN in most neurons”
Humansfrontotemporal dementia with GRN mutationsbrain
Journal of neuropathology and experimental neurology
Associations
1Mental processing speed
downin humans1
1 study
Mental processing speed
downin humans1
GRNMUTATION is associated with mental processing speed in humans (at baseline, versus healthy controls).
“At baseline, GRN mutation carriers showed lower scores on mental processing speed than healthy controls (p = 0.043).”
Humansat baseline, versus healthy controls
Presymptomatic cognitive decline in familial frontotemporal dementia: A longitudinal study
Neurology